Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

New Endograft Introduction System Enhances Physician Control During Minimally Invasive Treatment For Thoracic Aortic Aneurysms
In a development aimed at improving patient outcomes, physicians treating thoracic aortic aneurysms (TAA) will now experience a new level of control while placing endografts during thoracic endovascular repair procedures. With the launch of Cook Medical"s new Z-TRAK PLUS™ Introduction System, physicians are provided with improved maneuverability for controllable device orientation and deployment of the Zenith® TX2™ TAA Endovascular Stent Graft compared to earlier Cook delivery systems.

New Clinical Data Shows Significant Improvement In The Appearance Of Fat Using SlimLipo(TM) Laser
Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, announced the success of a clinical study showing the benefits of the SlimLipo body sculpting laser for laser-assisted lipolysis. Cleared by the Federal Drug Administration (FDA) in April of 2008, the SlimLipo laser is now available with 40 watts of power for faster, more effective treatments.
News of the day
State Regulators Embrace Health Reforms, But Insist Oversight Remains With Them
While state insurance regulators are working hard to keep most insurance oversight squarely in their hands, they are actively promoting new federal mandates and rules for health insurance-with a major caveat, according to a story in BestWeek U.S./Canada.
Cardiovascular

Alzheimer's Comment On Research That Genes In Early Onset Are Associated With Memory, Published In Nature, 28 July 2009

Memory is a fundamental function of nerve cells in the brain, and loss of memory is a key symptom in many people with Alzheimer"s disease. In order for memory to function correctly, nerve cells must be able to communicate effectively with each other. Many important proteins in the brain ensure that this communication is maintained between healthy nerve cells by monitoring the junctions, or synapses, between cells. This is also the location of production of amyloid-beta, which accumulates as plaques in Alzheimer"s disease. The gene PSEN1 is responsible for the protein presenilin1. Faulty versions of this gene are known to be linked to early onset Alzheimer"s disease. This new study shows that presenilin1 plays an important role in the functioning of synapses between nerve cells and suggests that the faulty protein disrupts communication between cells, thus affecting memory. The work also suggests that presenilin1 is linked with amyloid-beta and production of toxic plaques in the brain during Alzheimer"s disease. Alzheimer"s Society comment: "This study shows that a gene linked with early onset Alzheimer"s plays an important role in storing memory. This is an interesting finding which could lead to new research into how we can develop drug treatments that target this area. One million people will develop dementia in the next 10 years. We must act now. We need a national plan for dementia research and a tripling of investment to see research translated into better treatments for millions of people. Dementia is not a natural part of ageing; it is caused by diseases of the brain. 15,000 people under 65 live with dementia in the UK." Professor Clive Ballard Director of Research Alzheimer"s Society Reference Presenilins are essential for regulating neurotransmitter release. Chen Zhang1,2, Bei Wu1, Vassilios Beglopoulos1, Mary Wines-Samuelson1, Dawei Zhang1, Ioannis Dragatsis3, Thomas C. Su֬dhof2 & Jie Shen. Vol 460|30 July 2009| doi:10.1038/nature08177 Alzheimer"s Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009